1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Interferon Gamma Plus Camrelizumab as Neoadjuvant Therapy for Locally Advanced Esophageal Squamous Cell CarcinomaCamrelizumab; Locally Advanced Esophageal Squamous Cell Carcinoma; Neoadjuvant TherapyRecruitingPhase 22026-08-26NCT07787273